期刊文献+

Expressions of estrogen receptor subtypes and c-met proto-oncogene in endometrial carcinoma and their correlation 被引量:1

Expressions of estrogen receptor subtypes and c-met proto-oncogene in endometrial carcinoma and their correlation
下载PDF
导出
摘要 Objective To investigate the expressions of estrogen receptor(ER)subtypes and c-met proto-oncogene in human endometrial carcinomas and to assess the clinical significance of ER and c-met in this carcinoma.Methods Reverse transcription PCR(RT-PCR)was used to detect the expressions of ERα,ERβ and c-met proto-oncogene mRNA in 30 samples of endometrial carcinoma and 11 samples of normal endometrium.Results The expression of ERα in endometrial carcinoma(0.70±0.40)was significantly reduced in comparison to that in normal endometrium(1.14±0.56,P<0.05).A similar finding was made for the expression of ERβ in carcinoma(0.24±0.18)versus normal tissues(0.48±0.20,P<0.05).In contrast,c-met mRNA expression was increased in endometrial carcinoma(1.45±0.72)compared to that in normal endometrium(0.42±0.31,P<0.01).A decrease tendency of the expression of ERα was also found from Stage Ⅰ(0.82±0.41)to a more severe Stag Ⅱ-Ⅲ of endometrial carcinoma(0.42±0.17,P<0.05).The analysis of ERα and ERβ mRNA revealed a decrease tendency from shallow to deep invasion of the uterine muscles(P<0.05).We found that the expressions of ERα and ERβ were negatively correlated with c-met proto-oncogene with a coefficient correlation of-0.63(P<0.01)and-0.32(P<0.05),respectively.Conclusion ERα and ERβ are both involved in mutagenic action of carcinogen.C-met proto-oncogene plays an important role in the carcinogenesis and development of endometrial carcinoma.C-met and ER expressions show a negative correlation in the development of endometrial carcinoma. Objective To investigate the expressions of estrogen receptor(ER)subtypes and c-met proto-oncogene in human endometrial carcinomas and to assess the clinical significance of ER and c-met in this carcinoma.Methods Reverse transcription PCR(RT-PCR)was used to detect the expressions of ERα,ERβ and c-met proto-oncogene mRNA in 30 samples of endometrial carcinoma and 11 samples of normal endometrium.Results The expression of ERα in endometrial carcinoma(0.70±0.40)was significantly reduced in comparison to that in normal endometrium(1.14±0.56,P<0.05).A similar finding was made for the expression of ERβ in carcinoma(0.24±0.18)versus normal tissues(0.48±0.20,P<0.05).In contrast,c-met mRNA expression was increased in endometrial carcinoma(1.45±0.72)compared to that in normal endometrium(0.42±0.31,P<0.01).A decrease tendency of the expression of ERα was also found from Stage Ⅰ(0.82±0.41)to a more severe Stag Ⅱ-Ⅲ of endometrial carcinoma(0.42±0.17,P<0.05).The analysis of ERα and ERβ mRNA revealed a decrease tendency from shallow to deep invasion of the uterine muscles(P<0.05).We found that the expressions of ERα and ERβ were negatively correlated with c-met proto-oncogene with a coefficient correlation of-0.63(P<0.01)and-0.32(P<0.05),respectively.Conclusion ERα and ERβ are both involved in mutagenic action of carcinogen.C-met proto-oncogene plays an important role in the carcinogenesis and development of endometrial carcinoma.C-met and ER expressions show a negative correlation in the development of endometrial carcinoma.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2010年第1期54-58,共5页 药物分析学报(英文版)
关键词 estrogen receptor α estrogen receptor β c-met proto-oncogene endometrial carcinoma estrogen receptor α estrogen receptor β c-met proto-oncogene endometrial carcinoma
  • 相关文献

参考文献22

  • 1李雪,崔宇杰.c-Met抑制剂[J].医学分子生物学杂志,2008,5(1):78-81. 被引量:3
  • 2Stephen Byers,Morag Park,Connie Sommers,Stephen Seslar.Breast carcinoma: a collective disorder[J],1994.
  • 3Boehme K,Simon S,Mueller SO,et al.Gene expression pro-filing in Ishikawa cells:Afingerprint for estrogen active com-poundsToxicol Appl Phar macol,2009.
  • 4He YD,Peng ZL,Pan XL,et al.Expression and correlation of c-met and estrogen receptor in endometrial carcinomasJ Sichuan Univ (Med Sci Ed),2003.
  • 5Wu C,Liao QP.Expression of estrogen receptorsαandβin endometrial carcinoma and its clinical indicationChinese Journal of Obstetrics and Gynecology,2003.
  • 6Hart man J,Str m A,Gustafsson JA.Estrogen receptor beta in breast cancer—diagnostic and therapeutic implicationsSteroids,2009.
  • 7Maehle BO,Collett K,Tretli S,et al.Estrogen receptor be-ta—an independent prognostic marker in estrogen alpha and progesterone receptor-positive breast cancerActa Pathologica Microbiologica et Immunologica Scandinavica,2009.
  • 8Recio JA,Merlino G.Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1Oncegene,2002.
  • 9Yoshida S,Harada T,Mitsunari M,et al.Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathwaysJournal of Clinical Endocrinologv & Metabolism,2004.
  • 10Smuc T,Rizner TL.Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell linesChemico Biological Interactions,2009.

二级参考文献10

  • 1HEIDEMAN D A M,,OVERMEER R M,VAN BEUSECHEM V W,et al.Inhibition of angiogenesis and HGF-cMet-elicited malig-nant processes in human hepatocellular carcinoma cells using ade-noviral vector-mediated NK4gene therapy[].Cancer Gene Therapy.2005
  • 2WEN J,MATSUMOTO K,TANIURA N,et al.Inhibition of co-lon cancer growth and metastasis by NK4gene repetitive delivery in mice[].Biochemical and Biophysical Research Communications.2007
  • 3KONG-BELTRAN M,STAMOS J,WICKRAMASHINGHE D.The sema domain of Met is necessary for receptor dimerization and acti-vation[].Cancer Cell.2004
  • 4MARTENS T,SCHMIDT N O,ECKERICH C,et al.A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo[].Clinical Cancer Research.2006
  • 5PURI N,KHRAMTSOV A,AHMED S,et al.A selective small molecule inhibitor of c-Met,PHA665752,inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts[].Cancer Research.2007
  • 6MA P C,SCHAEFER E,CHRISTENSEN J G,et al.A selective small molecule c-MET inhibitor,PHA665752cooperates with ra-pamycin[].Clinical Cancer Research.2005
  • 7BERTHOUS,AEBERSOLD D M,SCHMIDTL S,et al.The Met kinase inhibitor SU11274exhibits a selective inhibition pattern to-ward different receptor mutated variant[].Oncegene.2004
  • 8XIE Q,GAO C F,SHINOMIYA N,et al.Geldanamycins exqui-sitely inhibit HGF/SF-mediated tumor cell invasion[].Oncegene.2005
  • 9BIRCHMEIER C,BIRCHMEIER W,GHERARDI E,et al.Met,metastasis,motility and more[].Nature Reviews Molecular Cell Biology.2003
  • 10TRUSOLINO L,COMOGLIO P M.Scatter-factor and semaphorin receptors:cell signalling for invasive growth[].Nature Reviews Cancer.2002

共引文献2

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部